Lauren Miller
Physician Assistant · Anniston, ALNPI 1003042078
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $307,534 of the $486,779 with a category attached, or 63.2%. It is spread thinly across 27 manufacturers, the largest accounting for just 19.1%. Among physician assistant clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,305 payments — averaging $373.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$93K
- AbbVie$69K
- Dermavant Sciences, Inc.$58K
- E.r. Squibb & Sons, L.L.C.$43K
- UCB, Inc.$42K
- Sanofi$41K
- plus $141K from 21 others
Across 1 payment — averaging $1400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1K
What the payments were for
- Consulting fees$89,51518%
- Speaking & faculty fees$307,53463%
- Travel & lodging$56,34512%
- Food & beverage$32,6817%
- Education$7030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 207 | $92,857 |
| AbbVie | 243 | $69,109 |
| Dermavant Sciences, Inc. | 127 | $58,079 |
| E.r. Squibb & Sons, L.L.C. | 124 | $42,592 |
| UCB, Inc. | 89 | $41,756 |
| Sanofi | 71 | $41,361 |
| Regeneron Healthcare Solutions, Inc. | 102 | $34,948 |
| Amgen | 85 | $34,611 |
| Organon | 26 | $13,477 |
| Incyte Corporation | 29 | $10,073 |
| Pfizer | 28 | $9,898 |
| Eli Lilly | 7 | $8,076 |
| Novartis | 48 | $6,937 |
| Arcutis Biotherapeutics, Inc. | 21 | $5,361 |
| Boehringer Ingelheim | 5 | $4,829 |
| LEO Pharma Inc. | 25 | $3,396 |
| Johnson & Johnson | 30 | $2,753 |
| Genentech USA, Inc. | 1 | $2,400 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $2,130 |
| EPI Health, LLC | 3 | $923 |
| Mayne Pharma Commercial LLC | 4 | $539 |
| Sun Pharmaceutical Industries Inc. | 13 | $305 |
| Galderma Laboratories, L.p. | 5 | $210 |
| Sanofi-aventis U.S. LLC | 3 | $83 |
| VYNE Pharmaceuticals Inc. | 2 | $46 |
| Botanix SB Inc | 1 | $16 |
| Journey Medical Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$486,779 in reported general payments places this provider in the 95th percentile of 846 physician assistant providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 15 | $94,327 |
| Dupixent PenDupilumab | 20 | $73,977 |
| SotyktuDeucravacitinib | 11 | $70,179 |
| Ciclopirox | 85 | $3,752 |
| Clobetasol Propionate | 40 | $3,138 |
| Acitretin | 11 | $2,420 |
| Fluocinonide | 46 | $2,119 |
| Tacrolimus | 12 | $1,293 |
| Doxycycline Hyclate | 55 | $983 |
| Desonide | 11 | $827 |
| Clindamycin Phosphate | 16 | $520 |
| Ketoconazole | 25 | $485 |
| Triamcinolone Acetonide | 34 | $477 |
| Terbinafine Hcl | 16 | $259 |
| Doxepin Hcl | 11 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $69,109 | $94,32715 claims |
| E.r. Squibb & Sons, L.L.C.Sotyktu | $42,592 | $70,17911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 846 physician assistant providers in Alabama.
Other physician assistant in Anniston
- Natalie GeorgeBirmingham$540K
- Brianna BarryEnterprise$29K
- Ashley PeaceMobile$27K
- Andrea WombleHuntsville$22K
- Valerie GoodwinBirmingham$21K
- Marlee BrunoDecatur$19K
- Mary TemplinBirmingham$19K
- Gregory SharpMobile$19K
- Elizabeth SimpsonMobile$18K
- Ellen Burch-BurkhalterMontgomery$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.